Stocks and InvestingStocks and Investing
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022
Tue, January 18, 2022

Matthew Harrison Maintained (ALVR) at Buy with Decreased Target to $45 on, Jan 18th, 2022


Published on 2024-10-27 19:18:48 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "AlloVir, Inc." (ALVR) at Buy with Decreased Target from $48 to $45 on, Jan 18th, 2022.

Matthew has made no other calls on ALVR in the last 4 months.



There is 1 other peer that has a rating on ALVR. Out of the 1 peers that are also analyzing ALVR, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, December 17th, 2021